FI103180B - Flurbiprofeenia sisältävien lääkkeiden valmistus kipujen ja/tai tulehd usten torjumiseksi eläimissä ja ihmisissä - Google Patents

Flurbiprofeenia sisältävien lääkkeiden valmistus kipujen ja/tai tulehd usten torjumiseksi eläimissä ja ihmisissä

Info

Publication number
FI103180B
FI103180B FI931097A FI931097A FI103180B FI 103180 B FI103180 B FI 103180B FI 931097 A FI931097 A FI 931097A FI 931097 A FI931097 A FI 931097A FI 103180 B FI103180 B FI 103180B
Authority
FI
Finland
Prior art keywords
inflammation
pain
humans
animals
preparation
Prior art date
Application number
FI931097A
Other languages
English (en)
Swedish (sv)
Other versions
FI103180B1 (fi
FI931097A (fi
FI931097A0 (fi
Inventor
Gerd Geisslinger
Kay Brune
Original Assignee
Paz Arzneimittelentwicklung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6414093&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI103180(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Paz Arzneimittelentwicklung filed Critical Paz Arzneimittelentwicklung
Publication of FI931097A publication Critical patent/FI931097A/fi
Publication of FI931097A0 publication Critical patent/FI931097A0/fi
Application granted granted Critical
Publication of FI103180B1 publication Critical patent/FI103180B1/fi
Publication of FI103180B publication Critical patent/FI103180B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI931097A 1990-09-12 1993-03-11 Flurbiprofeenia sisältävien lääkkeiden valmistus kipujen ja/tai tulehd usten torjumiseksi eläimissä ja ihmisissä FI103180B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4028906A DE4028906A1 (de) 1990-09-12 1990-09-12 Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
PCT/EP1991/001568 WO1992004018A1 (de) 1990-09-12 1991-08-19 Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen

Publications (4)

Publication Number Publication Date
FI931097A FI931097A (fi) 1993-03-11
FI931097A0 FI931097A0 (fi) 1993-03-11
FI103180B1 FI103180B1 (fi) 1999-05-14
FI103180B true FI103180B (fi) 1999-05-14

Family

ID=6414093

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931097A FI103180B (fi) 1990-09-12 1993-03-11 Flurbiprofeenia sisältävien lääkkeiden valmistus kipujen ja/tai tulehd usten torjumiseksi eläimissä ja ihmisissä

Country Status (14)

Country Link
US (2) US5206029A (fi)
EP (1) EP0607128B2 (fi)
JP (1) JP3305315B2 (fi)
AT (1) ATE158182T1 (fi)
AU (1) AU654498B2 (fi)
CA (1) CA2087723C (fi)
DE (2) DE4028906A1 (fi)
DK (1) DK0607128T4 (fi)
ES (1) ES2106785T5 (fi)
FI (1) FI103180B (fi)
GR (1) GR3025502T3 (fi)
HU (1) HU225887B1 (fi)
RU (1) RU2080116C1 (fi)
WO (1) WO1992004018A1 (fi)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140172C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Ibuprofen enthaltendes Arzneimittel
DE4216756C2 (de) * 1992-05-21 1994-08-25 Pharmatrans Sanaq Ag 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung
AU672269B2 (en) * 1992-12-02 1996-09-26 Aesica Pharmaceuticals Ltd Process for preparing substantially pure enantiomers of phenylpropionic acids
DE4319438C1 (de) * 1993-06-11 1994-06-01 Gerd Dr Dr Geislinger Arzneimittel auf der Grundlage von Ketoprofen zur Bekämpfung von Schmerzen und/oder Entzündungen und/oder Fieber an Menschen und Tieren
JP3782834B2 (ja) * 1994-10-26 2006-06-07 株式会社トクホン 鎮痛抗炎症貼付剤
IT1271800B (it) * 1994-12-27 1997-06-09 Zambon Spa Processo di preparazione degli enantiomeri dell'acido 2- (2-fluoro- 4-bifenil) propionico
US5955504A (en) * 1995-03-13 1999-09-21 Loma Linda University Medical Center Colorectal chemoprotective composition and method of preventing colorectal cancer
US5981592A (en) * 1995-03-13 1999-11-09 Loma Linda University Medical Center Method and composition for treating cystic fibrosis
US6160018A (en) * 1995-03-13 2000-12-12 Loma Linda University Medical Center Prophylactic composition and method for alzheimer's Disease
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
ES2253810T3 (es) * 1997-03-10 2006-06-01 Loma Linda University Medical Center Uso de r-aines para la prevencion de la enfermedad de alzheimer.
GB9705989D0 (en) * 1997-03-22 1997-05-07 Boots Co Plc Therapeutic composition
DE69933049T2 (de) * 1998-09-03 2007-10-04 Loma Linda University Medical Center, Loma Linda Pharmazeutische zusammensetzung und verwendung von rnsaid zur behandlung der entzündung
AU2004222809B2 (en) * 1998-09-03 2007-06-28 Loma Linda University Medical Center Pharmaceutical Composition and Method for Treatment of Inflammation
DE19907895A1 (de) * 1999-02-24 2000-11-16 Paz Arzneimittelentwicklung Verwendung von R-Arylpropionsäuren zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen bei Mensch und Tier, welche durch die Hemmung der Aktivierung von NF-kB therapeutisch beeinflußt werden können
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
US20060004086A1 (en) * 2000-04-13 2006-01-05 Mayo Foundation For Medical Education And Research Method of reducing Abeta42 and treating diseases
WO2001078721A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research Aβ42 LOWERING AGENTS
DE10047319A1 (de) * 2000-09-25 2002-04-18 Paz Arzneimittelentwicklung Verwendung von R-Arylpropionsäuren zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen, welche durch die Hemmung der Aktivierung des nukleären Transkriptionsfaktors AP-1 therapeutisch beeinflußt werden können
US6497901B1 (en) * 2000-11-02 2002-12-24 Royer Biomedical, Inc. Resorbable matrices for delivery of bioactive compounds
AU2002309963B2 (en) 2001-05-21 2007-03-01 Alcon, Inc. Use of NF-KAPPA-B inhibitors to treat dry eye disorders
US20030027867A1 (en) * 2001-06-29 2003-02-06 Myriad Genetics, Incorporated Use of R-NSAID compounds for anti-HIV treatment
US20030143165A1 (en) * 2002-01-25 2003-07-31 Allan Evans NSAID-containing topical formulations that demonstrate chemopreventive activity
US7247328B2 (en) * 2002-05-31 2007-07-24 Zinpro Corporation Chromium (III) alpha amino acid complexes
US7129375B2 (en) 2002-10-16 2006-10-31 Zinpro Corporation Metal complexes of α amino dicarboxylic acids
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
US6953507B2 (en) * 2003-03-21 2005-10-11 Ecolab Inc. Low temperature cleaning
WO2005065069A2 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
US20050171207A1 (en) * 2003-09-26 2005-08-04 Myriad Genetics, Incorporated Method and composition for combination treatment of neurodegenerative disorders
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
US20050252144A1 (en) * 2004-04-29 2005-11-17 Macdonald Robert A Veneers for walls, retaining walls and the like
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
NZ564789A (en) * 2005-07-22 2010-07-30 Myriad Genetics Inc High drug load formulations and dosage forms
US20070042094A1 (en) 2005-08-22 2007-02-22 Alcide Corporation Oxidation method and compositions therefor
WO2008006099A2 (en) * 2006-07-07 2008-01-10 Myriad Genetics, Inc. Treatment of psychiatric disorders
US20090162421A1 (en) * 2007-12-21 2009-06-25 Paz Arzneimittel-Entwicklungsgesellschaft Mbh Drugs as well as their production and use in the treatment of pain-associated neuropathies
MX2010006608A (es) * 2007-12-21 2010-10-05 Paz Arzneimittelentwicklung Composiciones farmaceuticas y produccion y uso de las mismas en el tratamiento de neuropatias asociadas con el dolor.
US20110269704A1 (en) * 2009-07-24 2011-11-03 Seigfried Bernd G Method for developing a liquid composition to be applied to the skin as a foam and a composition that can be applied topically
EP2468270A1 (en) 2010-12-21 2012-06-27 GALENpharma GmbH (R)-2-(3-fluoro-4-phenylphenyl)propionic acid for use in the treatment of skin diseases
WO2014015341A2 (en) * 2012-07-20 2014-01-23 Vanderbilt University Compositions and methods for substrate-selective inhibition of endocannabinoid oxygenation
US9578879B1 (en) 2014-02-07 2017-02-28 Gojo Industries, Inc. Compositions and methods having improved efficacy against spores and other organisms
CN113262216A (zh) * 2020-02-14 2021-08-17 北京泰德制药股份有限公司 一种用于消除皮表红肿镇痛的外用制剂
CN115536525B (zh) * 2022-09-23 2024-02-23 南京知和医药科技有限公司 一种s-（+）-氟比洛芬盐及其制备方法、药物组合物和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784705A (en) * 1964-01-24 1974-01-08 Boots Pure Drug Co Ltd Therapeutically active phenylalkane derivatives
GR64816B (en) * 1977-03-08 1980-06-03 Boots Co Ltd Resolution of flurbiprofen ii/iii
US4209638A (en) * 1977-03-08 1980-06-24 The Boots Company Limited Preparation of therapeutic agents
ZA828453B (en) † 1981-12-08 1983-12-28 Boots Co Plc Therapeutic agents
JPS6283885A (ja) † 1985-10-08 1987-04-17 Nitto Electric Ind Co Ltd 酵素固定膜及びその製造方法
US4927854A (en) * 1987-12-24 1990-05-22 Analgesic Associates Sustained/enhanced analgesia
AU6758990A (en) † 1989-11-06 1991-05-31 Sepracor, Inc. Analgesic composition containing optically pure s(+) flurbiprofen

Also Published As

Publication number Publication date
ES2106785T5 (es) 2007-10-16
DE4028906A1 (de) 1992-03-19
WO1992004018A1 (de) 1992-03-19
CA2087723A1 (en) 1992-03-13
RU2080116C1 (ru) 1997-05-27
EP0607128A1 (de) 1994-07-27
AU8335291A (en) 1992-03-30
FI103180B1 (fi) 1999-05-14
AU654498B2 (en) 1994-11-10
US5206029A (en) 1993-04-27
JPH06500313A (ja) 1994-01-13
DK0607128T4 (da) 2007-05-07
GR3025502T3 (en) 1998-02-27
HU9300636D0 (en) 1993-05-28
HU225887B1 (en) 2007-11-28
DK0607128T3 (da) 1998-04-14
ATE158182T1 (de) 1997-10-15
HUT63564A (en) 1993-09-28
FI931097A (fi) 1993-03-11
EP0607128B1 (de) 1997-09-17
FI931097A0 (fi) 1993-03-11
US5200198A (en) 1993-04-06
ES2106785T3 (es) 1997-11-16
DE4028906C2 (fi) 1992-10-29
DE59108854D1 (de) 1997-10-23
CA2087723C (en) 2002-07-23
EP0607128B2 (de) 2007-02-21
JP3305315B2 (ja) 2002-07-22

Similar Documents

Publication Publication Date Title
FI103180B1 (fi) Flurbiprofeenia sisältävien lääkkeiden valmistus kipujen ja/tai tulehdusten torjumiseksi eläimissä ja ihmisissä
ATE96308T1 (de) Dosierform fuer verabreichung in der humanmedizin.
ATE162399T1 (de) Terfanadin metaboliten und deren optisch reine isomere zur behandlung von allergischen krankheiten
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
NO306377B1 (no) Doseform for avgivelse av et medikament
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
DE68926746D1 (de) Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittel
PT92995A (pt) Metodo para o tratamento da disfuncao leucocita com gm-csf
ES2145902T3 (es) Aplicacion del riluzole en el tratamiento de las enfermedades mitocondriales.
PT651654E (pt) Utilizacao de um dimero de lisozima para a preparacao de um medicamento para modular os mecanismos natutais de defesa
AU5643299A (en) Humic acid and its use in the treatment of various conditions
KR900009029A (ko) 가축병 치료용 약물을 투여하는 장치
ATE141510T1 (de) Arzneimittel enthaltend cd14
KR950700737A (ko) 기도 염증 및 기도 과잉반응의 치료약품(Medicament for the treatment of airways inflammation and airways hyperresponsiveness)
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
PT84996A (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen
ES2124926T3 (es) Uso de desoxipergualina para la preparacion de un medicamento para el tratamiento de enfermedades inflamatorias e hiperreactivas.
ATE84418T1 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
IT1099795B (it) Composizione terapeutica per il trattamento di infezioni e malattie di animali da allevamento
Zhang The clinical study of cefamandole nafate.
NO873805D0 (no) Medisinsk doseringsanordning for uttoemning av forstoevet medikament for inhaleringsluft.